Anthony Delosreyes
Psychiatric/Mental Health · Seattle, WANPI 1699324129
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 164 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,831, 2.3 times the $1,254 reported in 2021. Among psychiatric/mental health clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 164 payments — averaging $53.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$2K
- Otsuka America Pharmaceutical, Inc.$1K
- Axsome Therapeutics, Inc.$669
- Johnson & Johnson$654
- AbbVie$609
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$550
- plus $3K from 17 others
What the payments were for
- Food & beverage$8,692100%
- Education$30%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 39 | $1,873 |
| Otsuka America Pharmaceutical, Inc. | 23 | $1,151 |
| Axsome Therapeutics, Inc. | 7 | $669 |
| Johnson & Johnson | 9 | $654 |
| AbbVie | 15 | $609 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $550 |
| Vanda Pharmaceuticals Inc. | 10 | $517 |
| Alkermes, Inc. | 5 | $421 |
| E.r. Squibb & Sons, L.L.C. | 6 | $384 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $345 |
| Sunovion Pharmaceuticals Inc. | 9 | $267 |
| Tris Pharma Inc | 3 | $258 |
| Teva Pharmaceuticals USA, Inc. | 3 | $192 |
| Braeburn Inc. | 3 | $178 |
| Jazz Pharmaceuticals Inc. | 3 | $159 |
| Corium, LLC | 4 | $133 |
| Biogen | 1 | $80 |
| Lundbeck LLC | 3 | $62 |
| Collegium Pharmaceutical, Inc. | 3 | $58 |
| Supernus Pharmaceuticals, Inc. | 2 | $46 |
| Bausch Health US, LLC | 2 | $42 |
| Sage Therapeutics, LLC | 1 | $30 |
| Noven Therapeutics, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$1,459
- INGREZZA$987
- REXULTI$720
- Auvelity$606
- CAPLYTA$526
- SPRAVATO$403
- VRAYLAR$356
- COBENFY$304
- Fanapt$241
- Quillichew ER$237
- Dyanavel XR$237
- Quillivant$237
- BRIXADI$126
- SUNOSI$125
- Austedo XR$124
- LATUDA$110
- Azstarys$100
How this compares
$8,695 in reported general payments places this provider in the 95th percentile of 931 psychiatric/mental health providers in Washington.
Other psychiatric/mental health in Seattle
- Kelly BlissSeattle$18K
- Shannon JacksonSeattle$8K
- Emma NaumanSeattle$4K
- Angela CombsRichland$121K
- Ashley McGinnisAuburn$26K
- Courtney YantPuyallup$26K
- Dawn MasonSpokane$25K
- Jennifer WilsonYakima$23K
- Kojo SarfoEllensburg$20K
- Brendan RoeVancouver$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.